LAKE TAHOE, Nev., Dec. 23, 2024 (GLOBE NEWSWIRE) — 2ONE Labs and Performance Plus Marketing ('PPM') have been granted a favorable Preliminary Injunction (‘PI’) Order relating to the ongoing trademark dispute [...] Read more »
UAE’S HADER SECURITY (HSC) AND TABBARA ELECTRONICS SECURE SUCCESSFUL REMOTE ROBOTIC INFRASTRUCTURE INSPECTION USING RAJANT KINETIC MESH
Malvern, Pennsylvania (USA), Dec. 19, 2024 (GLOBE NEWSWIRE) — Read more »
A operação da Syrah em Balama é a primeira mina de grafite a concluir uma auditoria independente de acordo com o padrão IRMA, tendo atingido o nível IRMA 50
SEATTLE, Dec. 19, 2024 (GLOBE NEWSWIRE) — Hoje, a Iniciativa para a Garantia de Mineração Responsável (IRMA) divulgou os resultados de uma auditoria independente da operação de grafite da Syrah em [...] Read more »
Syrah’s Balama is the first graphite operation to complete independent audit against the IRMA Standard, achieves IRMA 50
SEATTLE, Dec. 19, 2024 (GLOBE NEWSWIRE) — Today the Initiative for Responsible Mining (IRMA) released the results of an independent audit of Syrah’s Balama graphite operation (“Balama”) against the IRMA Standard for [...] Read more »
A Bitget se prepara para a conformidade MiCA com um futuro centro regional europeu
VICTORIA, Seychelles, Dec. 18, 2024 (GLOBE NEWSWIRE) — A Read more »
Bitget bereitet sich mit bevorstehendem europäischen Regionalzentrum auf MiCA-Konformität vor
VICTORIA, Seychellen, Dec. 18, 2024 (GLOBE NEWSWIRE) — Read more »
Bitget se prépare à l’entrée en application du cadre MiCA avec la création d’un futur hub régional européen
VICTORIA, Seychelles, 18 déc. 2024 (GLOBE NEWSWIRE) — Read more »
Brains Bioceutical Expande Oferta de Canabinóides Líder do Setor com D9-THC e CBN, Abrindo Novas Fronteiras para o Desenvolvimento de Medicamentos
VANCOUVER, British Columbia, Dec. 18, 2024 (GLOBE NEWSWIRE) — A Brains Bioceutical Corp. (Brains Bio), líder global em Ingredientes Farmacêuticos Ativos (APIs) de canabinóides naturais e compatíveis com [...] Read more »
Brains Bioceutical weitet das branchenführende Cannabinoid-Angebot auf D9-THC und CBN aus, um neue Grenzen in der Wirkstoffentwicklung zu erschließen
VANCOUVER, British Columbia, Dec. 18, 2024 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. (Brains Bio), ein weltweit führendes Unternehmen für natürliche GMP–konforme cannabinoide Pharmawirkstoffe (API), gibt die [...] Read more »
Brains Bioceutical élargit son offre de cannabinoïdes leaders sur le marché avec le D9-THC et le CBN, et ouvre ainsi de nouvelles possibilités en matière de développement de médicaments
VANCOUVER, Colombie–Britannique, 18 déc. 2024 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. (Brains Bio), leader mondial dans la fabrication d’ingrédients pharmaceutiques actifs (IPA) à base de [...] Read more »